ArticleProceedings of the National Academy of Sciences of the United States of America2014

Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist.

Celine Valant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.